sulfadiazine has been researched along with Retinal Pigment Epithelial Detachment in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mouinga Abayi, DA | 1 |
| Mve Mengome, E | 1 |
| Brady-McCreery, KM | 1 |
| Hussein, MA | 1 |
| Paysse, EA | 1 |
2 other studies available for sulfadiazine and Retinal Pigment Epithelial Detachment
| Article | Year |
|---|---|
[A macular retinal serous detachment complicating a toxoplasmic retinochorioditis].
Topics: Chorioretinitis; Drug Administration Schedule; Female; Fluorescein Angiography; Fundus Oculi; Humans | 2020 |
Congenital toxoplasmosis with unusual retinal findings.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, | 2003 |